Nicholas S Burris1, Monica Sigovan, Heather A Knauer, Elaine E Tseng, David Saloner, Michael D Hope. 1. From the *Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA; †CREATIS Laboratory, University of Lyon, Lyon, France; ‡School of Public Health, University of California, Berkeley; and §Department of Cardiothoracic Surgery, University of California, San Francisco, CA.
Abstract
OBJECTIVES: Altered systolic blood flow in the ascending aorta has been correlated with increased aortic growth in patients with bicuspid aortic valves (BAVs). We used conventional, 2-dimensional (2D) phase contrast magnetic resonance imaging (PC-MRI) to assess the relationship between altered flow and future growth in patients with BAV. MATERIALS AND METHODS: Aortic MRI data were reviewed for 17 adult patients with BAV with right-left leaflet fusion undergoing surveillance imaging who had 2D PC-MRI through their ascending aortas on an initial study, follow-up studies more than 1 year later, and an initial maximum aortic diameter of less than 4.5 cm. Diameters were measured at standard levels by 2 blinded reviewers. Normalized systolic flow displacement was calculated at peak systole from the PC-MRI data, and correlation with the interval aortic growth was performed, with adjustment for clinical/demographic factors. RESULTS: The average follow-up interval was 2.9 ± 1.3 years. Systolic flow displacement at the initial study strongly correlated with ascending aortic growth rate (r = 0.71, P < 0.005) with moderate, non-significant correlation between initial diameter and growth (r = 0.45, P = 0.214). Aortic growth was 4 times faster in patients with initial flow displacement of 0.2 or greater (n = 9) compared with those (n = 8) with initial flow displacement less than 0.2 (0.8 ± 0.4 vs 0.2 ± 0.3 mm/y; P = 0.002). CONCLUSIONS: Systolic flow displacement calculated from conventional 2D PC-MRI in the ascending aorta correlates with future aortic growth in patients undergoing routine surveillance imaging for BAV. With a cutoff valve of 0.2, flow displacement may be used to identify a subset of patients likely to have elevated growth rates and may better risk-stratify patients with BAV for aortic disease progression than vessel diameter alone.
OBJECTIVES: Altered systolic blood flow in the ascending aorta has been correlated with increased aortic growth in patients with bicuspid aortic valves (BAVs). We used conventional, 2-dimensional (2D) phase contrast magnetic resonance imaging (PC-MRI) to assess the relationship between altered flow and future growth in patients with BAV. MATERIALS AND METHODS: Aortic MRI data were reviewed for 17 adult patients with BAV with right-left leaflet fusion undergoing surveillance imaging who had 2D PC-MRI through their ascending aortas on an initial study, follow-up studies more than 1 year later, and an initial maximum aortic diameter of less than 4.5 cm. Diameters were measured at standard levels by 2 blinded reviewers. Normalized systolic flow displacement was calculated at peak systole from the PC-MRI data, and correlation with the interval aortic growth was performed, with adjustment for clinical/demographic factors. RESULTS: The average follow-up interval was 2.9 ± 1.3 years. Systolic flow displacement at the initial study strongly correlated with ascending aortic growth rate (r = 0.71, P < 0.005) with moderate, non-significant correlation between initial diameter and growth (r = 0.45, P = 0.214). Aortic growth was 4 times faster in patients with initial flow displacement of 0.2 or greater (n = 9) compared with those (n = 8) with initial flow displacement less than 0.2 (0.8 ± 0.4 vs 0.2 ± 0.3 mm/y; P = 0.002). CONCLUSIONS: Systolic flow displacement calculated from conventional 2D PC-MRI in the ascending aorta correlates with future aortic growth in patients undergoing routine surveillance imaging for BAV. With a cutoff valve of 0.2, flow displacement may be used to identify a subset of patients likely to have elevated growth rates and may better risk-stratify patients with BAV for aortic disease progression than vessel diameter alone.
Authors: Kapil Krishnan; Liang Ge; Henrik Haraldsson; Michael D Hope; David A Saloner; Julius M Guccione; Elaine E Tseng Journal: Interact Cardiovasc Thorac Surg Date: 2015-07-14
Authors: Lucia Mirabella; Alex J Barker; Neelakantan Saikrishnan; Elizabeth R Coco; Daniel J Mangiameli; Michael Markl; Ajit P Yoganathan Journal: Ann Biomed Eng Date: 2014-12-23 Impact factor: 3.934
Authors: Michael A Borger; Paul W M Fedak; Elizabeth H Stephens; Thomas G Gleason; Evaldas Girdauskas; John S Ikonomidis; Ali Khoynezhad; Samuel C Siu; Subodh Verma; Michael D Hope; Duke E Cameron; Donald F Hammer; Joseph S Coselli; Marc R Moon; Thoralf M Sundt; Alex J Barker; Michael Markl; Alessandro Della Corte; Hector I Michelena; John A Elefteriades Journal: J Thorac Cardiovasc Surg Date: 2018-08 Impact factor: 5.209
Authors: Emile S Farag; Emilio L Schade; Pim van Ooij; S Matthijs Boekholdt; R Nils Planken; Roland van Kimmenade; Aart J Nederveen; Bas A J M de Mol; Jolanda Kluin Journal: Int J Cardiovasc Imaging Date: 2019-02-11 Impact factor: 2.357
Authors: M Kelm; L Goubergrits; J Bruening; P Yevtushenko; J F Fernandes; S H Sündermann; F Berger; V Falk; T Kuehne; S Nordmeyer Journal: Sci Rep Date: 2017-08-29 Impact factor: 4.379